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Background and purpose: Stroke risk prediction scores have
been designed to stratify risk of recurrent cerebrovascular
events in patients with transient ischaemic attack (TIA) or
minor ischaemic stroke (MIS).
Material and methods: Consecutive patients with TIA or
MIS referring to Ghaem Hospital, Mashhad presenting
within 24 hours from the onset of symptoms were recruited
to the prospective cohort study between 2010 and 2011. MIS
was defined as an ischaemic stroke with National Institutes
of Health Stroke Scale (NIHSS) score < 4. The end-point
of the study was a new ischaemic cerebrovascular event or
vascular death at 90 days and, additionally, at 3 days after
the index TIA or MIS. The decision to admit and of method
of treatment in each case was left to the discretion of the stroke
neurologist. The predictive accuracy of the ABCD2 scoring
system for recurrent stroke or TIA was quantified by the area
under the curve (AUC), using the c-statistics.
Results: The study included 393 patients with TIA (238
males, 155 females) and 118 patients with MIS (77 males,
41 females). Among 511 patients with minor ischaemic
events, 117 strokes (23.2%), 99 TIAs (19.6%), and 11 vas-
cular deaths (2.2%) occurred within 3 months after the index
event. The ABCD2 score had a weak predictive value for 
3-month and 3-day recurrent stroke in patients with TIA
(AUC = 0.599 and 0.591, respectively), but a high predic-
tive value for 3-month and 3-day recurrent stroke in patients
with MIS (AUC = 0.727 and 0.728, respectively).
St reszczenie
Wstêp i cel pracy: Punktacjê oceny ryzyka wyst¹pienia uda-
ru mózgu opracowano w celu stratyfikacji ryzyka nawroto-
wego incydentu naczyniowego mózgu u pacjentów z napa-
dem przemijaj¹cego niedokrwienia mózgu (transient ischaemic
attack – TIA) lub niewielkim udarem niedokrwiennym mózgu
(minor ischae mic stroke – MIS).
Materia³ i metody: Do badania w³¹czono kolejnych chorych
zg³aszaj¹cych siê w latach 2010–2011 do szpitala Ghaem
w Mashad w ci¹gu 24 godzin od wyst¹pienia TIA lub MIS.
Niewielki udar niedokrwienny mózgu definiowano jako udar
niedokrwienny mózgu powoduj¹cy ubytkowe objawy neuro-
logiczne ocenione w skali National Institutes of Health Stroke
Scale (NIHSS) na < 4 pkt. Punktem koñcowym badania
by³o wyst¹pienie kolejnego incydentu naczyniowego mózgu
lub zgon w ci¹gu 90 dni, a dodatkowo równie¿ w ci¹gu 3 dni
od pierwszego zachorowania. Decyzjê o przyjê ciu do szpita-
la i o sposobie leczenia podejmowa³ neurolog specjalizuj¹cy
siê w chorobach naczyniowych mózgu. Do k³adnoœæ rokow-
nicz¹ skali ABCD2 w przewidywaniu wyst¹pienia nawroto-
wego udaru mózgu lub TIA oceniono liczbowo i okreœlono
iloœciowo metod¹ pola pod krzy w¹ (area under the curve –
AUC) z u¿yciem statystyki c.  
Wyniki: W badaniu wziê³o udzia³ 393 chorych na TIA 
(238 mê¿czyzn i 155 kobiet) oraz 118 chorych na MIS 
(77 mê¿czyzn i 41 kobiet). W grupie obejmuj¹cej ³¹cznie 
511 chorych z lekkimi incydentami naczyniowymi mózgu
w okresie 3 miesiêcy od wyst¹pienia pierwszego incydentu
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Introduction
Identification of those transient ischaemic attack
(TIA) and minor ischaemic stroke (MIS) patients at
high risk of recurrent stroke is an important aspect
of management to ensure an optimal risk- and cost-
benefit relation. A large number of TIA and MIS pa -
tients do not go on to experience an early stroke. Defi-
ning who is at risk for a subsequent event and what
actions should be taken immediately remains an impor-
tant clinical issue.
Predictive scores could help to raise awareness
of recurrent stroke risk in patients, which in turn might
improve adherence to prevention strategies [1]. Clini-
cal prediction rules may be the most helpful in triaging
these patients [2]. Stronger predictors of stroke recur-
rence are needed to enable practitioners to take clinical
decisions [3]. Clinical prediction scores have been deve-
loped with the aim of improving identification of TIA
subgroups at higher and lower early stroke risk, thus
aiding triage decisions in primary and secondary care
[4]. The usefulness of risk scores depends on predicti-
ve value, consistency of performance in different studies
and ease of calculation.
The ABCD2 score is a prognostic system based on
clinical data designed to predict stroke risk within 7 days
after TIA to guide the triage [5]. The ABCD2 score is
the most externally validated prediction tool currently
available [6]. This score has been independently vali-
dated in different clinical settings and is now recom-
mended for use in triaging TIA patients by several
major clinical guidelines [6]. Multiple validations
of the ABCD2 system have reported inconsistent results,
ranging from excellent predictive value to little better
than chance [5,6]. Evaluation of the use of the ABCD2
score in predicting incident vascular events in TIA and
MIS patients constitutes the aim of our study.
Material and methods
Consecutive TIA or MIS patients were prospecti-
vely evaluated in our hospital and stroke clinic between
2010 and 2011. Diagnosis of TIA or MIS was made 
by a stroke neurologist. Only those presenting within 
24 hours from the onset of symptoms were enrolled [7].
Patients had to access the hospital or stroke clinic within
24 hours after an event to enhance precise recall
of the type and duration of symptoms and to guarantee
inclusion of very short-term strokes [8]. Patients were
enrolled in this study if they had a premorbid modified
Rankin scale ≤ 1 [8]. Ischaemic stroke and TIA were
defined as a sudden focal neurological deficit of presu-
med arterial origin lasting ≥ 24 hours and < 24 hours,
respectively, with or without a corresponding ischaemic
lesion on brain imaging [1]. Minor ischaemic stroke
was considered as ischaemic stroke with a National Insti-
tutes of Health Stroke Scale (NIHSS) score < 4 [4].
Exclusion criteria were clinical evaluation beyond 
24 hours from the end of the transient event and a final
diagnosis of non-ischaemic causes of symptoms such as
migraine, seizure and anxiety [7]. Known cognitive
impairment and significant comorbidity limiting parti-
cipation in the study were also considered as exclusion
criteria. We excluded patients with disabling stroke, de -
fined as NIHSS ≥ 4 at 1 day after the event, to allow
for a more reliable assessment of recurrent events [1].
The end point of the study was a new ischaemic cere-
Conclusion: The ABCD2 score is highly predictive for short-
term recurrent stroke in patients with MIS but not in patients
with TIA, although it was originally designed for patients
with TIA. 
Key words: transient ischaemic attacks, infarction, brain,
recurrence, risk.
naczyniowego mózgu wyst¹pi³o 117 udarów mózgu (23,2%),
99 TIA (19,6%) i 11 zgonów z przyczyn naczyniowych
(2,2%). Wartoœæ predykcyjna punktacji ABCD2 w odniesie-
niu do wyst¹pienia nawrotowego udaru mózgu w okresie 
3 miesiêcy lub 3 dni po pierwotnym incydencie naczyniowym
by³a niewielka u pacjentów z TIA (wartoœæ AUC odpowied-
nio 0,599 i 0,591), a du¿a u pacjentów z MIS (wartoœæ AUC
odpowiednio 0,727 i 0,728).
Wniosek: Punktacja ABCD2 ma du¿¹ wartoœæ predykcyjn¹
wczesnego wyst¹pienia nawrotowego udaru mózgu u pacjen-
tów z MIS, ale nie z TIA, chocia¿ pierwotnie zosta³a zaprojek -
towana do u¿ycia w drugiej z tych populacji.
S³owa kluczowe: napady przemijaj¹cego niedokrwienia móz -
gu, zawa³, mózg, nawrót, ryzyko.
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brovascular event or vascular death at 90 days and addi-
tionally at 3 days. Recurrent TIA, stroke and vascular
death as well as hospital admission and ongoing medi-
cation were recorded [7]. Recurrent stroke was dia-
gnosed in patients in whom the initial symptoms had
already substantially or fully recovered (or reached sta-
bilization). We considered recurrent stroke as worsening
by at least 4 points in the initial NIHSS score or clear-
ly defined new symptoms of > 24 hours duration that
suggested a new ischaemic event [3,9]. Although there
may be natural stroke progression in the first 3 days, this
progression would be unusual in patients with initial
NIHSS < 4. A recurrent TIA was defined as a new
neurological symptom of < 24 hours duration that is
caused by focal ischaemia in the brain or retina [10,11].
Follow-up data were obtained from direct patient visits
at 3 and 90 days or by centralized telephone interview
if patients failed to attend the visit [3]. Follow-up was
continued until death or 3 months from the date of the
index event [10]. All recurrent TIA and strokes were
assessed and investigated by a stroke neurologist [7].
Vascular death was defined by acute coronary syndrome
or cerebrovascular syndrome certified as the cause of
death or contributing directly to death [10]. In patients
who had multiple recurrent events, the end point was
classified as the first recurrence after the index ischae -
mic event [9]. All patients had blood test, electrocar-
diogram (ECG), head scan and duplex ultrasound
of neck arterial trunks [3,12]. The decision to admit
and of method of treatment in each case was left to
the discretion of the stroke neurologist. We recommend -
ed strict control of vascular risk factors after discharge
in all cases. Antiplatelet therapy was recommended 
in the acute phase of all patients with the exception
of those patients with cardioembolic strokes, patients
already pretreated with antiplatelet therapy, and patients
with crescendo TIA or progressive stroke after antipla-
telet treatment in whom anticoagulation was initiated [3]. 
Using the ABCD2 score criteria, we analysed the fol-
lowing variables: age ≥ 60 years (1 point), initial hyper-
tension > 140 mm Hg (systolic) and/or > 90 mm Hg
(diastolic) (1 point); weakness (2 points); speech im-
pairment (without weakness 1 point); duration of symp-
toms ≥ 1 hour (2 points), 10 minutes to 1 hour (1 point);
and diabetes (1 point) for calculation of ABCD2 score
in each TIA or MIS patient. The ABCD2 score is cal-
culated by summing up points for five independent fac-
tors [13]. The score assigns 0 to 7 points. The ABCD2
score is a risk assessment tool designed to improve
the prediction of short-term stroke risk after a TIA.
The score is optimized to predict the risk of stroke with -
in 2 days after a TIA, but also predicts stroke risk within
90 days [14].
Estimation of discriminative ability of ABCD2 score in
TIA and MIS patients
The predictive accuracy of the ABCD2 scoring sys-
tem for TIA or stroke at 3 days and 90 days was quan-
ti fied by the area under the curve (AUC) from the re -
ceiver operating characteristic curves (ROC) analysis
(c-statistic) [1,4]. Values of AUC range from 0.5 (chan-
ce prediction and no discrimination) to 1.0 (perfect pre-
diction) [1,4]. The sensitivities and specificities of pre-
diction were determined at each cut-off of the score
[1,4].
The research was approved by the ethics committee
of Ghaem Hospital and each patient gave informed con-
sent to participate. There was no delay in any of the the-
rapeutic interventions in order to carry out the present
study [6].
Results
A total of 511 patients (315 males, 196 females) meet-
ing the eligibility criteria were recruited and completed
the follow-up study during 2010 and 2011. Three hun-
dred and ninety-three TIA patients (238 males, 155 fe -
males) and 118 MIS patients (77 males, 41 females)
enrolled in the study. 72.4% of the patients (370/511)
were admitted in hospital and the remainder were recru-
ited from our stroke clinic. The mean age of all patients
was 68.5 years (standard deviation [SD], 4.7) and
63.2% of the patients were ≥ 60 years of age. The elap-
sed time from symptom onset to evaluation of the index
event was < 24 hours in all cases (mean, 14.6 hours;
SD, 2.2). The mean age of TIA and MIS patients was
68.4 years and 66.2 years, respectively. One hundred
and seventeen strokes (23.2%), 99 TIAs (19.6%), and
11 vascular deaths (2.2%) occurred within 3 months
after the index event in the whole group of 511 patients
with minor ischaemic events. The estimated risk
of recurrent stroke, TIA and vascular death in our
cohort is illustrated in Table 1. Eleven vascular deaths
(4 males, 7 females) occurred during 3-month follow-
up of our whole cohort and 6 vascular deaths happened
at 3 days.
The values for ROC analysis for best results
of the ABCD2 score in predicting 3-day and 3-month
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Index event Follow-up event
3-day 3-day TIA 3-day 3-month 3-month TIA 3-month 
stroke vascular death stroke vascular death
TIA (n = 393) 132 (34%) 40 (10.2%) 2 (0.5%) 141 (35.9%) 108 (27.5%) 5 (1.3%)
MIS (n = 118) 7 (5.9%) 37 (31.5%) 4 (3.4%) 29 (24.6%) 71 (60.2%) 6 (5.1%)
TIA and MIS combined 104 (20.4%) 41 (8.1%) 6 (1.2%) 117 (22.9%) 99 (19.4%) 11 (2.2%) 
(n = 511)
Table 1. Number and percentage of patients with recurrent stroke, transient ischaemic attack and vascular death during 3-day and 3-month follow-up of whole cohort
TIA – transient ischaemic attack, MIS – minor ischaemic stroke
Index event/outcome event* ROC analysis, area under the curve Assessment of best ABCD2 score**
(95% confidence interval)
Sensitivity Specificity Best ABCD2 score
TIA/3-month recurrent stroke 0.599 (0.536-0.663) 100% 97.2% ≥ 2.5
MIS/3-month recurrent stroke 0.727 (0.602-0.852) 100% 76.9% ≥ 4.5
TIA/3-month recurrent TIA 0.535 (0.457-0.613) 100% 97.5% ≥ 1.5
MIS/3-month recurrent TIA 0.547 (0.403-0.692) 100% 96.1% ≥ 3.5
TIA/3-day recurrent stroke 0.591 (0.526-0.657) 100% 97.3% ≥ 1.5
MIS/3-day recurrent stroke 0.728 (0.588-0.868) 100% 45.6% ≥ 5.5
TIA/3-day recurrent TIA 0.569 (0.457-0.666) 100% 89.8% ≥ 2.5
MIS/3-day recurrent TIA 0.495 (0.349-0.641) 100% 96.2% ≥ 3.5
Table 2. Values for receiver-operating curve (ROC) analysis for ABCD2 score in predicting 3-day and 3-month recurrent ischaemic cerebrovascular events  
TIA – transient ischaemic attack, MIS – minor ischaemic stroke
*Six cases with vascular death at 3 days and 11 cases with vascular death at 3 months were omitted in c-statistics analysis
**The result variables of the best predictive ABCD2 score
recurrent ischaemic cerebrovascular events are provi-
ded in Table 2. On ROC analysis, the AUC (c-statistic)
for 3-month and 3-day recurrent stroke in our TIA
patients is 0.599 and 0.591, respectively. The ABCD2
score was weakly predictive of 3-month and 3-day 
risk of stroke recurrence in follow-up of our TIA pa -
tients. The ABCD2 score was trichotomized into low
scores (0-3), intermediate scores (4-5) and high (6-7)
scores [15].
Among our 393 TIA patients, 21.6% (85/393) had
low (0-3) ABCD2 scores, 52.9% (208/393) had inter-
mediate scores (4-5) and 24.2% (95/393) had high 
(6-7) scores. Low, intermediate and high ABCD2 sco-
res were observed in 24.2% (32/132), 36.4% (48/132)
and 40.2% (53/132) of TIA patients with stroke recur-
rence at 3 days. Low, intermediate and high ABCD2
scores constituted 22.7% (32/141), 36.9% (52/141) and
40.2% (57/141) of TIA patients who had stroke in 
3-month follow-up. The relation between 3-day and 
3-month recurrence of stroke, TIA or both and distri-
bution of ABCD2 score in our TIA patients was not
significant (p > 0.05).
Among our 118 MIS patients, 3.4% (4/118) had
a low (≤ 3) ABCD2 score, 49.2% (58/118) had a mode-
rate (4-5) score and 46.6% (55/118) had a high (6-7)
score. None of our 7 MIS patients who had recurrent
stroke in 3-day follow-up had a low or intermediate
ABCD2 score and all of them had a score of 6 or 7.
Recurrence of stroke occurred in 29 MIS patients
during 3-month follow-up. Low, intermediate and high
ABCD2 scores constituted 0% (0/29), 10.3% (3/29) and
89.6% (26/29) of our MIS patients who had stroke
recurrence in 3-month follow-up. The relation between
3-day and 3-month recurrence of stroke, TIA or both
in our MIS patients was not significant (p > 0.05).
Table 3 illustrates the relation of outcome events with
distribution of ABCD2 score in index groups. On ROC
analysis, the AUC (c-statistics) for 3-month and 3-day
recurrent stroke in our 118 MIS patients is 0.727 and
0.728, respectively. The ABCD2 score was highly pre-
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dictive of 3-month and 3-day risk of stroke recurrence
in follow-up of our MIS patients. Among our whole
cohort of 511 patients with minor ischaemic events,
17.4% (89/511) had low, 52.1% (266/511) had inter-
mediate and 29.4% (150/511) had high ABCD2 scores.
One hundred and four recurrent strokes (20.3%) occur-
red in 3 days of the whole cohort with minor ischaemic
events. Low, intermediate and high ABCD2 scores con-
stituted 29.8% (31/104), 35.6% (37/104) and 34.6%
(36/104) of our patients with recurrent stroke in 3 days
after the index event. One hundred and seventeen stro-
kes were observed during 3-month follow-up of our
whole group of 511 patients with minor ischaemic
events. Low, intermediate, and high ABCD2 scores con-
stituted 26.5% (31/117), 35% (41/117) and 38.5%
(45/117) of patients who had recurrent stroke during 
3-month follow-up. Distribution of ABCD2 score in
the whole cohort was not significantly related to recur-
rent stroke at 3 days and 3 months (p > 0.05). 
Discussion
The 3-day and 3-month rate of recurrent stroke in
our whole cohort with TIA or MIS was 20.4% and
22.9%, respectively. A prospective study of 345 TIA
patients in Spain was associated with 20% risk of stro-
ke within the next 90 days and half of these recurrent
events occurred in the first 3 days [15]. The risk of stro-
ke was 2.5% at 2 days in an Italian study of TIA patients
[7] and 11.1% at 90 days in another study in Canada
[4]. 711 patients with TIA or MIS were prospectively
recruited from five centres in the UK [10]. Recurrent
stroke and TIA occurred at 90 days in 4% and 14%
of the cohort, respectively [10]. A review of a Canadian
stroke registry found that the stroke risk at 30 days after
a first TIA was 8%, with half of these strokes occurring
within the first 2 days [16]. Thirty-four percent risk
of stroke at 3 days and 36% risk of stroke at 90 days in
our TIA patients is much higher than in other reported
studies [14,17,18]. The main reason for this high fre-
quency of recurrent stroke in our TIA patients is dia-
gnosis of index TIA by a stroke neurologist, which dimi-
nishes recruitment of migraine, seizure and neurotic
patients as probable TIA. The main indication for
admission of TIA patients in our centre is appearance
of multiple or crescendo TIAs. This group of TIA
patients are at greater risk than other cases [19]. Becau-
se 71.2% of our TIA patients had multiple TIAs and
TIA cases constituted 76.9% of our whole group, this
high rate of 3-day and 3-month stroke recurrence in our
TIA cohort is reasonable. An Italian cohort study
of TIA patients revealed that an ABCD score < 4 car-
ries a very low risk of subsequent stroke and could be
advocated as a reason not to admit such patients [7].
Rothwell et al. as creators of the initial ABCD score
found it highly predictive of 7-day risk of stroke in pro-
bable or definite TIA patients in an Oxfordshire popu-
lation [20]. The initial ABCD system was highly pre-
dictive of 7-day, 30-day and 90-day stroke risk (AUC
= 0.75) in TIA patients [7,21]. The initial ABCD 
score was also highly predictive of 30-day risk of stroke
in Greek TIA patients [12]. Another validation study
of 180 TIA patients confirmed high AUC of 0.78 for
90-day risk of stroke using the ABCD2 score [4].
Although the ABCD2 score validated well (AUC =
0.62-0.83) in its original validation cohorts in the UK
and California [13,14], the predictive capability rema-
ins modest and this score cannot replace clinical judg-
ment [22]. In a cohort of 559 probable TIA patients
Index event/outcome event* χ2 statistics df P-value
TIA/3-day stroke or TIA 11.384 7 0.123
Stroke/3-day stroke or TIA 4.050 5 0.542
Whole cohort/3-day stroke or TIA 7.770 7 0.352
TIA/3-day stroke 9.664 1 0.208
Stroke/3-day stroke 4.926 5 0.425
Whole cohort/3-day stroke 4.408 7 0.734
TIA/3-day TIA 4.049 7 0.774
Stroke/3-day TIA 2.245 5 0.814
Whole cohort/3-day TIA 4.341 7 0.701
TIA/3-month stroke or TIA 5.604 7 0.587
Stroke/3-month stroke or TIA 6.838 5 0.233
Whole cohort/3-month stroke or TIA 15.109 14 0.258
TIA/3-month stroke 6.931 7 0.436
Stroke/3-month stroke 3.595 5 0.609
Whole cohort/3-month stroke 10.379 7 0.183
TIA/3-month TIA 4.883 7 0.674
Stroke/3-month TIA 5.240 5 0.387
Whole cohort/3-month TIA 14.204 14 0.309
Table 3. The relation of outcome events with distribution of ABCD2 score 
in index groups
*Six cases with vascular death at 3 days and 11 cases with vascular death at 3 months were
omitted in analysis.
TIA – transient ischaemic attack
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residing in Oxfordshire, the relationship between the risk
of stroke at 7 days and both ABCD and ABCD2 sco-
res was strong (p < 0.0001) [23]. However, since no
score will presumably ever reach an absolute predictive
value, clinicians should be aware that some, albeit few,
patients deemed to be at very low risk will still go on to
have a stroke [7]. In the Dublin TIA study, when each
ABCD2 item was analysed individually, there were no
associations with stroke at 7, 28 or 90 days and the AUC
for 7 days, 28 days and 90 days stroke was 0.49, 0.55
and 0.55, respectively [24]. The ABCD2 score perfor-
med no better than chance for prediction of 90-day stro-
ke in the Dublin TIA study, largely related to the fact
that 24.2% of patients who experienced a recurrence had
low scores [24]. When the ABCD2 score was trichoto-
mized into low (0-3 pts), intermediate (4-5 pts), and
high (6-7 pts) categories in the Dublin TIA study,
a trend toward higher 90-day stroke risk was observed
in the intermediate (10.7%) group compared to high
(5.3%) and low (4.8%) groups [24]. The ABCD2 score
was modestly predictive (AUC = 0.62, AUC = 0.62)
of stroke recurrence after MIS at 7 days and 90 days,
respectively, in the Oxfordshire area [25]. Another vali-
dation study of the ABCD system revealed that its dis -
criminatory ability is not optimal and TIA patients with
a score of 0 to 3 still had a significant probability of hav -
ing stroke within 90 days [26]. Therefore, ABCD score
had limited clinical utility in risk stratification of acute
TIA patients [26]. Another prospective study of 500
TIA patients was performed by Rothwell et al. Recur-
rent TIA and stroke were detected in 11% and 10%
of their cohort within 7 days [9]. The ABCD2 score
was highly predictive of major recurrent stroke (AUC
= 0.80, p < 0.0001), weakly predictive of minor stroke
(AUC = 0.57, p = 0.26), and inversely related to risk
of recurrent TIA (AUC = 0.37, p = 0.001) [9]. The-
refore, the ABCD2 predicted severity of recurrent events
after TIA [9]. In general, the score was predictive
of the 7-day risk of any stroke after TIA (AUC = 0.71,
p < 0.001) [9]. The ABCD2 appeared to predict seve-
rity of recurrent events rather than risk of any recurrent
event in TIA patients [9].
There are few published data on the risk of recur-
rent TIA after minor ischaemic cerebrovascular events
[9]. It should be stressed, however, that the ABCD2
score was developed for TIA patients alone. The dura-
tion factor, for instance, is useless for MIS patients [27],
and all of them will take an ABCD2 score of ≥ 2 based
on the duration item.
The ASPIRE approach for TIA and MIS patients
defined high-risk patients for stroke recurrence at 
90 days as those with any of the following components:
ABCD2 score ≥ 4; motor or speech symptoms lasting
longer than 5 minutes; patients with atrial fibrillation
[28]. The ASPIRE approach had an AUC of 0.62 in
discrimination of high-risk patients for stroke at 90 days
[28]. However, none of the ASPIRE items were asso-
ciated with risk of stroke in univariate and multivariate
analysis of our patients.
The Essen stroke risk score was designed for pre-
diction of stroke, myocardial infarction and vascular
death in 1-year follow-up of the REACH registry which
includes TIA or MIS patients [29]. The corresponding
AUC of the Essen stroke risk score was low (0.56) [29].
The Essen stroke risk score and SPI-II were not better
than chance for prediction of recurrent stroke at 7 days
and 90 days in index TIA or MIS patients in another
study (AUC = 0.50, AUC = 0.48) and they had a low
positive predictive value [25]. Thus, physicians may
question the usefulness of predictive scores in daily cli-
nical practice [1].
Conclusions
1. In patients with minor ischaemic events, clinical sco-
res will never replace clinical acumen, and a high-risk
etiology should be managed urgently, whatever the
risk is on a clinical score.
2. The ABCD2 score is highly predictive of short-term
recurrent stroke in MIS patients but not TIA cases,
although it was originally designed for patients with
TIA.
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